Adaptive Biotechnologies Corporation (ADPT) at a glance

Adaptive Biotechnologies Corporation (ADPT) is a mid-cap Healthcare company. It trades at $23.38, with a -16.8% profit margin and revenue growth of 35.1%. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Growth (92/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$23.38

Market cap

$2.82B

P/E ratio

n/a

Dividend yield

None

Beta

2.15

52-week range

$12.00 to $26.87